At Novartis, we innovate, develop and operate on a vast scale. You can be part of it. Join our creative community of professionals and you will find opportunities to make an unprecedented impact – on ...
Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each ...
Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each ...
Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each ...
The Philippine Press Institute (PPI) held a health reporting workshop to help local journalists gain a deeper understanding of low-density lipoprotein cholesterol (LDL-C or “bad cholesterol”) ...
Porto Salvo, 6 de novembro de 2024 – Mourad Aboubakr é o novo Presidente da Novartis, Portugal. Há 15 anos na Novartis, Mourad tem uma vasta experiência no mercado farmacêutico, tendo assumido várias ...
Novartis Ireland were very proud that our Customer Engagement Platform team has won the Industry Pharma Award for Best Use of Technology. We were delighted that our team's innovation and commitment to ...
Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each ...
La leucemia mieloide aguda (LMA) es un tipo de cáncer que se origina en las células sanguíneas. El cáncer se origina debido a ciertos cambios concretos que ocurren en el interior del ADN de las ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback